Global Biological Safety Testing Market Opportunities and Forecast 2023-2030
- DLR2399
- 14 May, 2022
- Pharma & Healthcare
- Pages: 120
- Global
Global Biological Safety Testing Market, By Product (Reagents & kits, Instruments, Services), By Application (Vaccines & Therapeutics, Blood & Blood-based Products, Gene Therapy, Tissue & Tissue-based Products, Stem Cell), By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Others) and opportunities and forecast 2023-2030
Biological Safety Testing Market Overview
The global market for biological safety testing is expected to witness tremendous growth in the forthcoming period. Some prominent factors are contributing significantly to the market’s growth, such as increasing awareness towards medicare and healthcare in developing countries, rising old age population, and growing incidence of cancer across the world. Furthermore, the rising need for biologics has resulted in remarkable growth in the number of biopharmaceutical companies. Companies are taking efforts to develop therapeutically advanced drugs on a large scale along with improving productivity and cost-efficiency. Therefore, companies are implementing good manufacturing practices involving exhaustive biological testing at various levels of the production cycle. Thus, the increasing use of biological safety testing in the biotechnology and pharmaceutical industries is positively impacting the overall growth of the market.
Moreover, according to the FDA, the number of new biologics approved in the US increased from 22 in 2016 to 48 in 2019. Hence, rising investments by biopharmaceutical companies to develop biologics and biosimilars are further projected to increase the number of approved products across the globe. This fact eventually boosting the growth of the biological safety testing market over the forecast period. As well, the rising number of government initiatives to promote biological safety testing products and services is expected to drive the overall growth of the market in near future.
Biological Safety Testing Market Segment Overview
Based on the product, the reagents & kits segment is expected to witness remarkable growth in the market. This is because of the increasing popularity and introduction of more effective and innovative technologies by the leading companies operating in the global market. Additionally, the services segment has the largest share of the market. This is due to the limited finances of biopharmaceutical manufacturers, complex manufacturing requirements, large investments required for establishing manufacturing facilities, and others, all of which have prompted the shift towards the outsourcing of biologics safety testing to service providers.
Biological Safety Testing Regional Overview
North America holds the major share of the biological safety testing market and this trend is expected to continue during the forecast period. This is attributed to high investments in biotechnology and the development of new biologics, vaccines, & drugs in the region. In addition, increasing investment for R&D by companies is one of the key factors responsible for the market’s growth. Europe is the second big region for the biological safety testing market. Similarly, the Asia Pacific is expected to register the fastest growth during the forecast period. Various factors such as rising healthcare expenditure and increasing awareness about the benefits of these products are expected to fuel the growth of the market in this region. Moreover, Latin America is projected to expand at a sluggish pace in the near future. This is due to the increasing awareness about these biological safety devices and the huge presence of leading manufacturers in the region.
Biological Safety Testing Market, Key Players
· NuAire
· Paragon Bioservices Inc.
· Nordic Scientific & Natural Solutions
· Toxikon Inc.
· SGS SA
· Charles River Laboratories International, Inc.
· BSL Bioservice Scientific Laboratories GmbH
· Lonza Group AG
· Milliporesigma
· Sartorius Stedim BioOutsource Limited
· Samsung BioLogics
Biological Safety Testing Market Segmentation
Biological Safety Testing Market, By Product
· Reagents & kits
· Instruments
· Services
Biological Safety Testing Market, By Application
· Vaccines & Therapeutics
· Blood & Blood-based Products
· Gene Therapy
· Tissue & Tissue-based Products
· Stem Cell
Biological Safety Testing Market, By Test Type
· Endotoxin Tests
· Sterility Tests
· Cell Line Authentication & Characterization Tests
· Bioburden Tests
· Adventitious Agent Detection Tests
· Residual Host Contamination Detection Tests
· Others
Biological Safety Testing Market, By Region
Biological Safety Testing Market Overview
The global market for biological safety testing is expected to witness tremendous growth in the forthcoming period. Some prominent factors are contributing significantly to the market’s growth, such as increasing awareness towards medicare and healthcare in developing countries, rising old age population, and growing incidence of cancer across the world. Furthermore, the rising need for biologics has resulted in remarkable growth in the number of biopharmaceutical companies. Companies are taking efforts to develop therapeutically advanced drugs on a large scale along with improving productivity and cost-efficiency. Therefore, companies are implementing good manufacturing practices involving exhaustive biological testing at various levels of the production cycle. Thus, the increasing use of biological safety testing in the biotechnology and pharmaceutical industries is positively impacting the overall growth of the market.
Moreover, according to the FDA, the number of new biologics approved in the US increased from 22 in 2016 to 48 in 2019. Hence, rising investments by biopharmaceutical companies to develop biologics and biosimilars are further projected to increase the number of approved products across the globe. This fact eventually boosting the growth of the biological safety testing market over the forecast period. As well, the rising number of government initiatives to promote biological safety testing products and services is expected to drive the overall growth of the market in near future.
Biological Safety Testing Market Segment Overview
Based on the product, the reagents & kits segment is expected to witness remarkable growth in the market. This is because of the increasing popularity and introduction of more effective and innovative technologies by the leading companies operating in the global market. Additionally, the services segment has the largest share of the market. This is due to the limited finances of biopharmaceutical manufacturers, complex manufacturing requirements, large investments required for establishing manufacturing facilities, and others, all of which have prompted the shift towards the outsourcing of biologics safety testing to service providers.
Biological Safety Testing Regional Overview
North America holds the major share of the biological safety testing market and this trend is expected to continue during the forecast period. This is attributed to high investments in biotechnology and the development of new biologics, vaccines, & drugs in the region. In addition, increasing investment for R&D by companies is one of the key factors responsible for the market’s growth. Europe is the second big region for the biological safety testing market. Similarly, the Asia Pacific is expected to register the fastest growth during the forecast period. Various factors such as rising healthcare expenditure and increasing awareness about the benefits of these products are expected to fuel the growth of the market in this region. Moreover, Latin America is projected to expand at a sluggish pace in the near future. This is due to the increasing awareness about these biological safety devices and the huge presence of leading manufacturers in the region.
Biological Safety Testing Market, Key Players
· NuAire
· Paragon Bioservices Inc.
· Nordic Scientific & Natural Solutions
· Toxikon Inc.
· SGS SA
· Charles River Laboratories International, Inc.
· BSL Bioservice Scientific Laboratories GmbH
· Lonza Group AG
· Milliporesigma
· Sartorius Stedim BioOutsource Limited
· Samsung BioLogics
Biological Safety Testing Market Segmentation
Biological Safety Testing Market, By Product
· Reagents & kits
· Instruments
· Services
Biological Safety Testing Market, By Application
· Vaccines & Therapeutics
· Blood & Blood-based Products
· Gene Therapy
· Tissue & Tissue-based Products
· Stem Cell
Biological Safety Testing Market, By Test Type
· Endotoxin Tests
· Sterility Tests
· Cell Line Authentication & Characterization Tests
· Bioburden Tests
· Adventitious Agent Detection Tests
· Residual Host Contamination Detection Tests
· Others
Biological Safety Testing Market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Reagents & kits
- 5.2.2. Instruments
- 5.2.3. Services
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Vaccines & Therapeutics
- 5.3.2. Blood & Blood-based Products
- 5.3.3. Gene Therapy
- 5.3.4. Tissue & Tissue-based Products
- 5.3.5. Stem Cell
- 5.4. Market Analysis, Insights and Forecast – By Test Type
- 5.4.1. Endotoxin Tests
- 5.4.2. Sterility Tests
- 5.4.3. Cell Line Authentication & Characterization Tests
- 5.4.4. Bioburden Tests
- 5.4.5. Adventitious Agent Detection Tests
- 5.4.6. Residual Host Contamination Detection Tests
- 5.4.7. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Reagents & kits
- 6.2.2. Instruments
- 6.2.3. Services
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Vaccines & Therapeutics
- 6.3.2. Blood & Blood-based Products
- 6.3.3. Gene Therapy
- 6.3.4. Tissue & Tissue-based Products
- 6.3.5. Stem Cell
- 6.4. Market Analysis, Insights and Forecast – By Test Type
- 6.4.1. Endotoxin Tests
- 6.4.2. Sterility Tests
- 6.4.3. Cell Line Authentication & Characterization Tests
- 6.4.4. Bioburden Tests
- 6.4.5. Adventitious Agent Detection Tests
- 6.4.6. Residual Host Contamination Detection Tests
- 6.4.7. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Reagents & kits
- 7.2.2. Instruments
- 7.2.3. Services
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Vaccines & Therapeutics
- 7.3.2. Blood & Blood-based Products
- 7.3.3. Gene Therapy
- 7.3.4. Tissue & Tissue-based Products
- 7.3.5. Stem Cell
- 7.4. Market Analysis, Insights and Forecast – By Test Type
- 7.4.1. Endotoxin Tests
- 7.4.2. Sterility Tests
- 7.4.3. Cell Line Authentication & Characterization Tests
- 7.4.4. Bioburden Tests
- 7.4.5. Adventitious Agent Detection Tests
- 7.4.6. Residual Host Contamination Detection Tests
- 7.4.7. Others
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Reagents & kits
- 8.2.2. Instruments
- 8.2.3. Services
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Vaccines & Therapeutics
- 8.3.2. Blood & Blood-based Products
- 8.3.3. Gene Therapy
- 8.3.4. Tissue & Tissue-based Products
- 8.3.5. Stem Cell
- 8.4. Market Analysis, Insights and Forecast – By Test Type
- 8.4.1. Endotoxin Tests
- 8.4.2. Sterility Tests
- 8.4.3. Cell Line Authentication & Characterization Tests
- 8.4.4. Bioburden Tests
- 8.4.5. Adventitious Agent Detection Tests
- 8.4.6. Residual Host Contamination Detection Tests
- 8.4.7. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Reagents & kits
- 9.2.2. Instruments
- 9.2.3. Services
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Vaccines & Therapeutics
- 9.3.2. Blood & Blood-based Products
- 9.3.3. Gene Therapy
- 9.3.4. Tissue & Tissue-based Products
- 9.3.5. Stem Cell
- 9.4. Market Analysis, Insights and Forecast – By Test Type
- 9.4.1. Endotoxin Tests
- 9.4.2. Sterility Tests
- 9.4.3. Cell Line Authentication & Characterization Tests
- 9.4.4. Bioburden Tests
- 9.4.5. Adventitious Agent Detection Tests
- 9.4.6. Residual Host Contamination Detection Tests
- 9.4.7. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product
- 10.2.1. Reagents & kits
- 10.2.2. Instruments
- 10.2.3. Services
- 10.3. Market Analysis, Insights and Forecast – By Application
- 10.3.1. Vaccines & Therapeutics
- 10.3.2. Blood & Blood-based Products
- 10.3.3. Gene Therapy
- 10.3.4. Tissue & Tissue-based Products
- 10.3.5. Stem Cell
- 10.4. Market Analysis, Insights and Forecast – By Test Type
- 10.4.1. Endotoxin Tests
- 10.4.2. Sterility Tests
- 10.4.3. Cell Line Authentication & Characterization Tests
- 10.4.4. Bioburden Tests
- 10.4.5. Adventitious Agent Detection Tests
- 10.4.6. Residual Host Contamination Detection Tests
- 10.4.7. Others
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. NuAire
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Paragon Bioservices Inc.
- 11.6. Nordic Scientific & Natural Solutions
- 11.7. Toxikon Inc.
- 11.8. SGS SA
- 11.9. Charles River Laboratories International, Inc.
- 11.10. BSL Bioservice Scientific Laboratories GmbH
- 11.11. Lonza Group AG
- 11.12. Milliporesigma
- 11.13. Sartorius Stedim BioOutsource Limited
List of Figures
Figure 1: Global Biological Safety Testing Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Biological Safety Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Figure 1: Global Biological Safety Testing Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Biological Safety Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Biological Safety Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Biological Safety Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Report You Might be Interested
Choose License Type
- USD
- GBP
- EURO
- INR
